Managing Gonorrhea and Its Complications: A Case-Based Approach

Presenters

Khalil G. Ghanem, MD, PhD
Khalil G. Ghanem, MD, PhD
Johns Hopkins University School of Medicine

January 19, 2021

10:00 AM PT to 11:15 AM PT

Overview

Assessment of Needs

The IAS–USA offers this state-of-the-art activity as part of a nationwide continuing education effort for physicians. The rates of gonorrhea continue to increase in the United States as does the extent of gonococcal antimicrobial resistance. In this webinar, we will consider the epidemiology of Neisseria gonorrhoeae, including the re-emergence of disseminated gonococcal infections, we will discuss the optimal diagnostic approaches, and the emerging therapeutic challenges.

Learning Objectives

On completion of this webinar, learners will be able to:

  • Describe the epidemiology of gonorrhea including drug-resistant gonorrhea
  • Develop an approach that optimizes the diagnosis of urogenital, extragenital, and disseminated gonococcal infections, including infections caused by suspected drug-resistant strains
  • Define the optimal approach to treating gonococcal infections, including infections in penicillin-allergic patients

Registration

Who Should Attend

This  webinar is designed for clinical decision makers who are actively involved in sexually transmitted infection care and research.

This activity is also relevant for registered nurses, pharmacists, and other health professionals.

Individual registration is required, even if you are viewing as a group, in order to receive continuing education credit or a certificate of participation.

Registration closes on Monday, January 19, 2021, 4:00 PM (PT).

Conflicts of Interest

In the interest of maintaining the independence of its continuing education activities, and in accordance with the policies of the Accreditation Council for Continuing Medical Education (ACCME), the IAS–USA requires all persons with control of content (eg, faculty, IAS–USA Board members, and program staff) to disclose any financial relationships with ineligible companies (previously defined as “commercial interests”) that they or their spouses or partners have had within the past 24 months. Any real or apparent conflicts of interest of those parties are resolved prior to the continuing education activity being delivered. Individuals who refuse to disclose financial interests may not participate in an IAS–USA continuing education activity.

The ACCME defines ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Presenter Disclosure

Dr Ghanem receives royalties from UpToDate. (Updated 12/14/20)

All relevant financial relationships have been mitigated.

Continuing Education Credits

CME Credits

The International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The IAS–USA designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Points

ABIM MOCSuccessful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Nursing Credits

Educational Review Systems is an approved approver of continuing nursing education by the Alabama State Nursing Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.  Provider # 5-115.  This program is approved for 1.25 hours of continuing nursing education.

Educational Review Systems is also approved for nursing continuing education by the state of California, the state of Florida and the District of Columbia.

This program is approved for 1.25 hours of pharmacotherapy credit.

Pharmacy Credits

Accreditation Council for Pharmacy Education logo Educational Review Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. Participants of the session who complete the evaluation and provide accurate NABP e-Profile information will have their credit for 1.25 contact hours (0.125 CEU) submitted to CPE Monitor as early as 14 days after the event and no later than 60 days after the event. Please know that if accurate e-Profile information is not provided within 60 days of the event, credit cannot be claimed after that time. The participant is accountable for verifying the accurate posting of CE credit to their CPE Monitor account within 60 days.
UAN # 0761-9999-21-011-L01-P

Grant Support

This activity is part of the IAS–USA national educational effort that is funded, in part, by charitable contributions from commercial companies. Per IAS–USA policy, any effort that uses commercial grants must receive grants from several companies with competing products. Funds are pooled and distributed to activities at the sole discretion of the IAS–USA. Grantors have no input into any activity, including its content, development, or selection of topics or speakers. Generous support for this activity has been received from the following contributors.

PLATINUM SUPPORTERS

Gilead Sciences, Inc
Merck & Co, Inc
ViiV Healthcare

SILVER SUPPORTER

Janssen Therapeutics

Frequently Asked Questions

View our list of FAQs about attending a webinar.

Further Questions?
Please contact the registration department at registration@iasusa.org or 415-544-9400.